M B Vidriales
Overview
Explore the profile of M B Vidriales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanoja-Flores L, Flores-Montero J, Garces J, Paiva B, Puig N, Garcia-Mateo A, et al.
Blood Cancer J
. 2018 Nov;
8(12):117.
PMID: 30455467
Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma...
2.
Puig N, Sarasquete M, Balanzategui A, Martinez J, Paiva B, Garcia H, et al.
Leukemia
. 2013 Jul;
28(2):391-7.
PMID: 23860448
We have analyzed the applicability, sensitivity and prognostic value of allele-specific oligonucleotide real-time quantitative PCR (ASO RQ-PCR) as a method for minimal residual disease (MRD) assessment in patients with multiple...
3.
Kalina T, Flores-Montero J, van der Velden V, Martin-Ayuso M, Bottcher S, Ritgen M, et al.
Leukemia
. 2012 Sep;
26(9):1986-2010.
PMID: 22948490
The EU-supported EuroFlow Consortium aimed at innovation and standardization of immunophenotyping for diagnosis and classification of hematological malignancies by introducing 8-color flow cytometry with fully standardized laboratory procedures and antibody...
4.
van Dongen J, Lhermitte L, Bottcher S, Almeida J, van der Velden V, Flores-Montero J, et al.
Leukemia
. 2012 May;
26(9):1908-75.
PMID: 22552007
Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody...
5.
Suarez L, Vidriales M, Sanz G, Lopez A, Lopez-Berges M, de Santiago M, et al.
Leukemia
. 2004 Apr;
18(7):1311-3.
PMID: 15116120
No abstract available.
6.
San Miguel J, Vidriales M, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez M, et al.
Semin Oncol
. 2003 Apr;
30(2):187-95.
PMID: 12720134
Immunophenotyping has become an essential tool for diagnosis of hematological malignancies. By contrast, for diagnosis of Waldenstrom's macroglobulinemia (WM) immunophenotyping is used only occasionally. From 150 patients with a IgM...
7.
San Miguel J, Vidriales M, Diaz-Mediavilla J, Gutierrez N, Canizo C, Ramos F, et al.
Blood
. 2001 Sep;
98(6):1746-51.
PMID: 11535507
Early response to therapy is one of the most important prognostic factors in acute leukemia. It is hypothesized that early immunophenotypical evaluation may help identify patients at high risk for...
8.
San Miguel J, Ciudad J, Vidriales M, Orfao A, Lucio P, Porwit-Macdonald A, et al.
Crit Rev Oncol Hematol
. 2000 Jan;
32(3):175-85.
PMID: 10633847
No abstract available.
9.
Martinez A, San Miguel J, Vidriales M, Ciudad J, Caballero M, Lopez-Berges M, et al.
Cytometry
. 1999 May;
38(2):70-5.
PMID: 10323219
During conventional follow-up of patients with acute myeloid leukemia (AML), the emergence of cytopenias is considered to be a sign of impending relapse, and it represents an example of how...
10.
San Miguel J, Martinez A, Macedo A, Vidriales M, Gonzalez M, Caballero D, et al.
Blood
. 1997 Oct;
90(6):2465-70.
PMID: 9310499
A high complete remission rate is currently achieved in patients with acute myeloid leukemia (AML). However, many patients eventually relapse due to the persistence of low numbers of residual leukemic...